Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment

NCT04613297 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT04613297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04613297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2020
Completion date
July 19, 2022
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19